Investing.com - Bruker (NASDAQ: BRKR) reported third quarter EPS of $0.60, in line with the analyst estimate of $0.60. Revenue for the quarter came in at $864.4M versus the consensus estimate of $866.46M.
Guidance
Bruker sees FY 2024 EPS of $2.36-$2.41 versus the analyst consensus of $2.60.
Bruker sees FY 2024 revenue of $3.34B-$3.37B versus the analyst consensus of $3.40B.
Bruker's stock price closed at $59.35. It is down -4.27% in the last 3 months and up 5.70% in the last 12 months.
Bruker saw 0 positive EPS revisions and 8 negative EPS revisions in the last 90 days. See Bruker's stock price’s past reactions to earnings here.
According to InvestingPro, Bruker's Financial Health score is "good performance".
Check out Bruker's recent earnings performance, and Bruker's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar